sergio nemorio hidalgo-figueroa
Instituto Potosino de InvestigaciĂłn CientĂfica y TecnolĂłgica (IPICYT)
San Luis PotosĂ, Mexico
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
Instituto Potosino de InvestigaciĂłn CientĂfica y TecnolĂłgica (IPICYT)
San Luis PotosĂ, Mexico
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
Universidade Federal de Goiás
Goiânia, Brazil
Review Editor
Anti-Infective Agents
The University of Queensland
Brisbane, Australia
Review Editor
Neurological Drugs
Brigham and Women's Hospital, Harvard Medical School
Boston, United States
Review Editor
Neurological Drugs
Schoool of Arts, Sciences and Humanities, University of Sao Paulo
SĂŁo Paulo, Brazil
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
Guangzhou Medical University
Guangzhou, China
Review Editor
Anti-inflammatory and Immunomodulating Agents
China Pharmaceutical University
Nanjing, China
Review Editor
Anti-Cancer Drugs
School of Medicine, Tufts University
Boston, United States
Review Editor
Cardiovascular and Hematologic Drugs
Comenius University
Bratislava, Slovakia
Review Editor
Anti-Infective Agents
Minia University
Minya, Egypt
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
Tufts Medical Center
Boston, United States
Review Editor
Cardiovascular and Hematologic Drugs
Temple University
Philadelphia, United States
Review Editor
Neurological Drugs
University of Modena and Reggio Emilia
Modena, Italy
Review Editor
Anti-Infective Agents
University of Rajshahi
Rajshahi, Bangladesh
Review Editor
Anti-Cancer Drugs
Department of Pharmacy, Khulna University
Khulna, Bangladesh
Review Editor
Anti-Infective Agents
Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona
Barcelona, Spain
Review Editor
Dermatologic Drugs